NEW YORK (GenomeWeb) – Signal Genetics today announced conditional approval from the US Food and Drug Administration for its Myeloma Prognostic Risk Signature genetic test for use as entry criteria for a clinical trial to treat high-risk multiple myeloma patients.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.